| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.097 | 0.07 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |